糖尿病诱导的MDM2 SNP309T→G改变促进异常视网膜血管生成
研究探讨MDM2 SNP309G与增殖性糖尿病视网膜病变(PDR)的关联及其促血管生成机制。发现PDR患者纤维血管膜中MDM2 SNP309G频率高,且存在T→G转换;高糖环境可诱导该转换,增强MDM2表达和血管生成反应。人源化小鼠携带SNP309G表现出加重的病理性视网膜新生血管。
要点
- MDM2 SNP309G与增殖性糖尿病视网膜病变(PDR)相关。
- 高糖环境促进视网膜内皮细胞中MDM2 SNP309T向G转换。
- SNP309G通过MDM2-VEGF正反馈环路促进病理性血管生成。
核心结论
- MDM2 SNP309G驱动MDM2和VEGF信号的正反馈环路,促进病理性血管生成。
- 靶向MDM2第二启动子可能成为预防PDR异常血管生成的新策略。
研究设计与样本
- 采用Sanger测序检测PDR患者血液和纤维血管膜及PVR患者视网膜前膜中MDM2 SNP309状态。
- 使用ELISA定量PDR或PVR患者玻璃体中8-oxo-2'-脱氧鸟苷水平。
- 通过prime editing在人视网膜微血管内皮细胞(HRECs)中引入MDM2 SNP309G,评估体外血管生成活性。
- 使用氧诱导视网膜病变(OIR)模型评估携带MDM2 SNP309T或SNP309G的人源化小鼠的病理性视网膜新生血管。
主要发现
- 110例PDR患者中,60.1%的纤维血管膜携带MDM2 SNP309G,20.9%的纤维血管膜与匹配血液相比存在309位T→G替换。
- PDR患者玻璃体中8-oxo-2'-脱氧鸟苷水平较PVR对照显著升高(7.8±1.2倍)。
- 原代HRECs长期暴露于高浓度D-葡萄糖的玻璃体液可抑制8-氧鸟嘌呤DNA糖苷酶表达,促进MDM2 SNP309T向G转换(36.1%),并增加MDM2蛋白水平。
- Prime editing介导HRECs中MDM2 SNP309T向G转换(51.6%)进一步增强高糖诱导的MDM2表达和体外血管生成反应。
- 携带MDM2 SNP309G的人源化C57BL/6J小鼠在OIR模型中表现出视网膜MDM2、HIF-1α、磷酸化VEGFR2、磷酸化Erk1/2和磷酸化Sp1水平升高,玻璃体中VEGF升高,以及加重的病理性视网膜血管生成。
临床怎么用
- MDM2 SNP309G可能作为PDR的遗传易感标志物。
- 靶向MDM2第二启动子可能为预防PDR异常血管生成提供新思路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The 309G SNP in the second promoter of the gene encoding mouse double minute 2 (MDM2) has been implicated in multiple human diseases. The aims of this study were to determine whether MDM2 SNP309G is associated with proliferative diabetic retinopathy (PDR), and whether it contributes to pathological angiogenesis. METHODS: Sanger DNA sequencing was used to determine the MDM2 SNP309 status in peripheral blood and fibrovascular membranes (FVMs) from individuals with PDR, as well as in epiretinal membranes from individuals with proliferative vitreoretinopathy (PVR). An ELISA was used to quantify the levels of the oxidative DNA damage biomarker 8-oxo-2'-deoxyguanosine in vitreous humour samples from individuals with PDR or PVR. Prime editing was employed to introduce MDM2 SNP309G into primary human retinal microvascular endothelial cells (HRECs), which were then assessed for in vitro angiogenic activities, including proliferation, migration and tube formation. A mouse model of oxygen-induced retinopathy (OIR) was used to evaluate pathological retinal neovascularisation in humanised mice carrying MDM2 SNP309T or SNP309G. Quantitative RT-PCR and western blot analyses were performed to assess gene and protein expression related to MDM2-mediated signalling pathways. RESULTS: An association between MDM2 SNP309G and PDR was identified. Among 110 individuals with PDR, 60.1% harboured MDM2 SNP309G in their FVMs, and 20.9% exhibited a T→G substitution at position 309 in FVMs compared with matched blood samples. The vitreous humour from individuals with PDR contained significantly higher levels of 8-oxo-2'-deoxyguanosine (7.8±1.2-fold) compared with PVR control participants. Chronic exposure of primary HRECs to vitreous humour containing a high concentration of D-glucose suppressed expression of 8-oxoguanine DNA glycosylase, promoted conversion of MDM2 SNP309T to G (36.1%), and increased MDM2 protein levels. Prime editing-mediated conversion of MDM2 SNP309T to G in HRECs (51.6%) further enhanced high-glucose-induced MDM2 expression and angiogenic responses in vitro. In vivo, humanised C57BL/6J mice carrying MDM2 SNP309G exhibited increased retinal levels of MDM2, hypoxia-inducible factor-1α (HIF-1α), phosphorylated vascular endothelial growth factor receptor 2 (VEGFR2), phosphorylated Erk1/2 and phosphorylated specificity protein 1 (Sp1), together with elevated vascular endothelial growth factor (VEGF) in the vitreous humour, and exacerbated pathological retinal angiogenesis in the OIR model, compared with mice harbouring MDM2 SNP309T. CONCLUSIONS/INTERPRETATION: These findings suggest that MDM2 SNP309G drives a positive feedback loop involving MDM2 and VEGF signalling in vascular endothelial cells, thereby promoting pathological angiogenesis. Targeting the second promoter of MDM2 may represent a novel therapeutic strategy for preventing aberrant angiogenesis in PDR.
引用
- Ma G, Wu W, Duan Y, et al. A diabetes-induced change of MDM2 SNP309T→G contributes to aberrant retinal angiogenesis. Diabetologia. 2026. PMID: 41770245. doi:10.1007/s00125-026-06695-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。